Zhao Suhua, Kong Jiehua, Li Shuling, Tong Zishun, Yang Chanjuan, Zhong Huaqing
Guangzhou Brain Hospital, Guangzhou, China.
Shanghai Arch Psychiatry. 2014 Feb;26(1):15-21. doi: 10.3969/j.issn.1002-0829.2014.01.003.
The negative symptoms of schizophrenia are not effectively treated with antipsychotic medications. Repetitive transcranial magnetic stimulation (rTMS) is an alternative approach that may be more effective in treating negative symptoms, but there has been little research comparing the effectiveness of different rTMS stimulation protocols.
Compare the effect of four different rTMS protocols in the treatment of the negative symptoms of schizophrenia.
Ninety-six patients with schizophrenia who had prominent negative symptoms were randomly assigned to four treatment groups: 10 Hz, 20 Hz, theta burst stimulation (TBS), and mock rTMS (i.e., the control group). In the first three groups, the left dorsolateral prefrontal cortex was stimulated at 80% of the motor threshold five times per week for four weeks. Before and after the treatment, evaluators who were blind to the group assignment of patients administered the Positive and Negative Syndrome Scale (PANSS), the Scale for the Assessment of Negative Symptoms (SANS) and the Treatment Emergent Symptom Scale (TESS).
Three of the 96 patients dropped out during the trial (two from the control group and one from the 20 Hz group). Compared to the control group, after 4 weeks of rTMS treatment all three treatment groups had lower scores on the PANSS negative symptom subscale, the PANSS general psychopathology subscale, and the SANS. The TBS group had significantly larger reductions in these scores than the 10 Hz group and the 20 Hz group, but there were no significant differences between the 10 Hz and 20 Hz groups. There were no pre- versus post-treatment differences in the PANSS positive symptom subscale scores between the four groups. No serious adverse events occurred and there were no statistically significant differences in the TESS scores across the four groups.
We find that rTMS, particularly the TBS stimulation protocol for rTMS, is a safe and effective treatment method for patients with schizophrenia who have prominent negative symptoms. Longitudinal studies with large samples are needed to optimize the rTMS treatment, to identify the stimulation protocol, duration, intensity and treatment interval that provides the best therapeutic result at the lowest risk to the patient.
抗精神病药物无法有效治疗精神分裂症的阴性症状。重复经颅磁刺激(rTMS)是一种替代方法,可能在治疗阴性症状方面更有效,但很少有研究比较不同rTMS刺激方案的有效性。
比较四种不同rTMS方案治疗精神分裂症阴性症状的效果。
96例有明显阴性症状的精神分裂症患者被随机分为四个治疗组:10赫兹、20赫兹、theta爆发刺激(TBS)和模拟rTMS(即对照组)。在前三组中,以运动阈值的80%每周刺激左侧背外侧前额叶皮质5次,共4周。治疗前后,对患者分组情况不知情的评估者使用阳性和阴性症状量表(PANSS)、阴性症状评估量表(SANS)和治疗中出现的症状量表(TESS)进行评估。
96例患者中有3例在试验期间退出(2例来自对照组,1例来自20赫兹组)。与对照组相比,rTMS治疗4周后,所有三个治疗组在PANSS阴性症状分量表、PANSS总体精神病理分量表和SANS上的得分均较低。TBS组在这些得分上的降低幅度明显大于10赫兹组和20赫兹组,但10赫兹组和20赫兹组之间没有显著差异。四组在PANSS阳性症状分量表得分上治疗前后没有差异。未发生严重不良事件,四组在TESS得分上没有统计学显著差异。
我们发现rTMS,特别是rTMS的TBS刺激方案,对于有明显阴性症状的精神分裂症患者是一种安全有效的治疗方法。需要进行大样本的纵向研究来优化rTMS治疗,确定能以最低患者风险提供最佳治疗效果的刺激方案、持续时间、强度和治疗间隔。